To print a PDF of this article CLICK HERE

To download an audio podcast CLICK HERE

Current statistics have shown that countries with the highest dairy consumption including Finland, Sweden, England and U.S. also have the highest rates of fractures and osteoporosis and are most likely the most vitamin D deficient.

According to many studies, the factors for osteoporosis is about 70% genetic and 30% environmental. Caucasians and Asians usually have lower bone density values than African Americans, Hispanics, and Latino Americans. The most important genes in the Nutrition Genome Report for bone health according to research is the vitamin D receptor gene (VDR), SHBG, APOE, GPX1, and SOD. We are currently researching a new interleukin -6 (IL-6) polymorphism and its connection to bone density.

VDR Polymorphisms and Bone Health

The regulation of the VDR gene is the most important gene for the efficiency of calcium absorption into the bone. Out of all of the papers published between 2000 and 2013 looking at the VDR polymorphisms Fok1 and Bsm1 and osteoporosis risk on postmenopausal women, more than 50% studies reported a significant relationship between Fok1, Bsm1, and osteoporosis. The VDR receptor requires magnesium, calcium, vitamin A, vitamin K, boron and zinc.

SHBG Polymorphisms and Bone Health

Several studies found an inverse correlation between serum SHBG levels and bone mineral density in both males and females.

One study showed that serum SHBG concentration is increased in middle-aged men with primary or secondary osteoporosis and is correlated with bone remodeling markers, hip bone mineral density, and vertebral fracture risk. Serum SHBG level was significantly higher (+42.2%), whereas free androgen index was lower (-24.8%) in patients with primary or secondary osteoporosis. Testosterone and estradiol levels did not correlate with any bone resorption or bone formation markers for men. Another study found that osteoporotic Chinese men had lower free testosterone (FT) and higher levels of SHBG.

In postmenopausal women with SHBG polymorphisms, subjects with the A allele (GA+AA) for the rs1799941, had a trend for lower free estradiol index compared to the GG genotype. They also had a significantly lower bone mineral density (BMD) at the intertrochanter of the hip and trend for lower BMD at the total hip.


APOE 4/4 Genotype and Bone Health

One of the benefits of the APOE 4/4 genotype is a higher intestinal absorption of dietary vitamin D and calcium, promoting stronger bones. The ancestral E4 allele is known as the hunter-gatherer allele before agriculture.

Early research believed that hunter-gatherers were usually hungry, tired and sick; and that things were much better once people began growing their own food and living in permanent villages. We now know the opposite is true. Hunter-gatherers were extremely healthy and Neolithic farmers were not. Paleopathologists tell us that foragers had excellent teeth, they were rarely malnourished, they were taller than most people today, and they didn’t suffer from endemic or epidemic diseases. The skeletons of early Neolithic farmers show scurvy, rickets, poor dental health, bone infections and a stature roughly 6 inches shorter than the hunter-gatherers.

Boron and Bone Health

Bone health requires vitamin D, calcium, magnesium, zinc, copper, silicon, vitamin K1, K2, vitamin C, inositol, L-arginine and boron. Cadmium and lead exposure cause the loss of essential metals, which leads to complications such as iron-deficiency anemia and osteoporosis. Boron improves VDR receptor function and stabilizes and extends the half-life of vitamin D and estrogen. Approximately half the population in the United States consumes less than 1 mg of boron per day. Supplementation with 3 mg of boron per day for post-menopausal women has demonstrated improved calcium and magnesium retention by the kidneys, and British Journal of Nutrition found that subjects that consumed dried plums (rich in boron) had significantly higher bone mineral density in the ulna (one of two long bones in the forearm) and spine, in comparison with the group that ate dried apples.

Estrogen’s Role as an Antixodant for Osteoporosis

This is from Week 8, but I wanted to include it here.

Researchers know that estrogen deficiency causes bone loss, but the mechanisms involved have proven to be complex and multifaceted. One of the pathways is believed to be estrogen’s role as an antioxidant.

In post-menopausal osteoporotic women, osteoblastic activity (bone building) is consistently depressed as osteoclastic activity (breaks down bone) is enhanced, indicating that reactive oxygen species play a major role in bone metabolism. Glutathione peroxidase and superoxide dismutase activity have been found to be significantly lower in osteoporotic women, suggesting that compromised antioxidant defenses play an important role in the development of osteoporosis. This hypothesis was tested in mice using N-acetylcysteine, which stimulated osteoblasts by increasing glutathione, while completely blocking bone loss associated with ovariectomy.

Hops contain the compounds xanthohumol and 8-prenylnaringenin. Xanthohumol has been characterized a ‘broad-spectrum’ cancer preventative. 8-prenylnaringenin is a prenylflavonoid and is the most potent phytoestrogen known to date. Biological activities suggest that prenylflavonoids from hops have the potential for application in cancer prevention programs and in prevention or treatment of post-menopausal ‘hot flashes’ and osteoporosis. Studies showing that beer increased bone density in post-menopausal women led researchers to think that it was the silicon content that was responsible. Since IPA beers were used, which have the highest hop content, it may actually have been the phytoestrogens in the hops mimicking the protective effect of estrogen, like genistein in soy.

IL6 Polymorphisms and Bone Health

The IL6  gene interacts with the estradiol/estrogen receptor complexes to regulate IL-6 gene expression. Functional polymorphisms in the promoter region of IL6 are known to be involved in bone mineral density (BMD) and the development of osteoporosis, however, the findings have been inconsistent. We are currently researching an IL6 polymorphism for bone density that currently isn’t included in the Nutrition Genome Report, but may be added in our next gene update.


Review the following genes in the Nutrition Genome Report for bone health.


Submit a Comment

Your email address will not be published. Required fields are marked *